What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?

Saved in:
Bibliographic Details
Published in:Neuro-oncology (Charlottesville, Va.) Va.), 2023-11, Vol.25 (11), p.1915-1917
Main Authors: Preusser, Matthias, Geurts, Marjolein, Hainfellner, Johannes A, van den Bent, Martin J
Format: Article
Language:English
Subjects:
Brain Neoplasms
Central Nervous System
Glioma
Humans
Isocitrate Dehydrogenase - genetics
Mutation
World Health Organization
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1522-8517
1523-5866
1523-5866
DOI:10.1093/neuonc/noad113